Sophie Lefort

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al. · Blood · 2010 · 1.6K citations · Full text

Medicine, Hematology, Oncology +10

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

M. Khellaf, J.-F. Viallard, M. Hamidou et al. · Haematologica · 2013 · 98 citations · Full text

Medicine, Hematology, Pharmacology +13

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

Emmanuel Bachy, Roch Houot, F. Morschhauser et al. · Haematologica · 2013 · 85 citations · Full text

Medicine, Immunology, Oncology +11

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home

Mohamed Touati, Ludovic Lamarsalle, Stéphane Moreau et al. · Supportive Care in Cancer · 2016 · 32 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Molecular signals in antigen presentation

Akira Tominaga, Sophie Lefort, Steven B. Mizel et al. · Clinical Immunology and Immunopathology · 1983 · 24 citations

Life Sciences, Immunology, Molecular Biology +14